Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.

Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.
复制标题

DOI:
10.1186/1742-4690-8-97
复制
发表时间:
2011-12-05
期刊:
影响因子:
3.3
通讯作者:
Blankson JN
Blankson JN
中科院分区:
医学2区
文献类型:
--
作者:
Salgado M;Rabi SA;O'Connell KA;Buckheit RW 3rd;Bailey JR;Chaudhry AA;Breaud AR;Marzinke MA;Clarke W;Margolick JB;Siliciano RF;Blankson JN

文献摘要

参考文献

相似文献

While initiation of highly active antiretroviral therapy (HAART) during primary HIV-1 infection occasionally results in transient control of viral replication after treatment interruption, the vast majority of patients eventually experience a rebound in plasma viremia. Here we report a case of a patient who was started on HAART during symptomatic primary infection and who has subsequently maintained viral loads of < 50 copies/mL for more than nine years after the cessation of treatment. This patient had a high baseline viral load and has maintained a relatively high frequency of latently infected CD4+ T cells. In addition, he does not have any known protective HLA alleles. Thus it is unlikely that he was destined to become a natural elite controller or suppressor. The mechanism of control of viral replication is unclear; he is infected with a CCR5/CXCR4 dual-tropic virus that is fully replication-competent in vitro. In addition, his spouse, who transmitted the virus to him, developed AIDS. The patient's CD4+ T cells are fully susceptible to HIV-1 infection, and he has low titers of neutralizing antibodies to heterologous and autologous HIV-1 isolates. Furthermore, his CD8+ T cells do not have potent HIV suppressive activity. This report suggests that some patients may be capable of controlling pathogenic HIV-1 isolates for extended periods of time after the cessation of HAART through a mechanism that is distinct from the potent cytotoxic T lymphocyte (CTL) mediated suppression that has been reported in many elite suppressors.
DOI: 10.1371/journal.pmed.0010036
发表时间: 2004-11
期刊: PLoS medicine
影响因子: 15.8
作者:
Kaufmann DE;Lichterfeld M;Altfeld M;Addo MM;Johnston MN;Lee PK;Wagner BS;Kalife ET;Strick D;Rosenberg ES;Walker BD
通讯作者: Walker BD
DOI: 10.1086/653677
发表时间: 2010-07-15
期刊: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子: --
作者:
Julg B;Pereyra F;Buzón MJ;Piechocka-Trocha A;Clark MJ;Baker BM;Lian J;Miura T;Martinez-Picado J;Addo MM;Walker BD
通讯作者: Walker BD
DOI: 10.1038/ng934
发表时间: 2002-08-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Martin, MP;Gao, XJ;Carrington, M
通讯作者: Carrington, M
DOI: 10.1172/jci44539
发表时间: 2011-04-01
影响因子: 15.9
作者:
Chen, Huabiao;Li, Chun;Lichterfeld, Mathias
通讯作者: Lichterfeld, Mathias
DOI: 10.1128/jvi.01369-07
发表时间: 2007-11-01
影响因子: 5.4
作者:
Brockman, Mark A.;Schneidewind, Arne;Allen, Todd M.
通讯作者: Allen, Todd M.